Phase 2/3 clinical trial results shows early promise for an inhaled insulin spray in people with mild cognitive impairment (MCI) or mild Alzheimer’s disease.
A study published today in JAMA Neurology found that physical activity may protect against cognitive decline and the build up of amyloid beta protein, a hallmark of Alzheimer’s disease.
New research presented today (Tuesday 16th July) at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles identified a number of differences in the progression and risk of Alzheimer’s disease between women and men.